1. Home
  2. RPTX vs SNAL Comparison

RPTX vs SNAL Comparison

Compare RPTX & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPTX
  • SNAL
  • Stock Information
  • Founded
  • RPTX 2016
  • SNAL 2000
  • Country
  • RPTX Canada
  • SNAL United States
  • Employees
  • RPTX N/A
  • SNAL N/A
  • Industry
  • RPTX Biotechnology: Pharmaceutical Preparations
  • SNAL Computer Software: Prepackaged Software
  • Sector
  • RPTX Health Care
  • SNAL Technology
  • Exchange
  • RPTX Nasdaq
  • SNAL Nasdaq
  • Market Cap
  • RPTX 53.2M
  • SNAL 59.1M
  • IPO Year
  • RPTX 2020
  • SNAL 2022
  • Fundamental
  • Price
  • RPTX $0.93
  • SNAL $0.96
  • Analyst Decision
  • RPTX Strong Buy
  • SNAL
  • Analyst Count
  • RPTX 3
  • SNAL 0
  • Target Price
  • RPTX $4.50
  • SNAL N/A
  • AVG Volume (30 Days)
  • RPTX 266.1K
  • SNAL 55.2K
  • Earning Date
  • RPTX 05-06-2025
  • SNAL 05-14-2025
  • Dividend Yield
  • RPTX N/A
  • SNAL N/A
  • EPS Growth
  • RPTX N/A
  • SNAL N/A
  • EPS
  • RPTX N/A
  • SNAL 0.05
  • Revenue
  • RPTX $53,477,000.00
  • SNAL $84,467,047.00
  • Revenue This Year
  • RPTX N/A
  • SNAL $26.80
  • Revenue Next Year
  • RPTX $2.61
  • SNAL N/A
  • P/E Ratio
  • RPTX N/A
  • SNAL $17.88
  • Revenue Growth
  • RPTX 4.58
  • SNAL 38.69
  • 52 Week Low
  • RPTX $0.89
  • SNAL $0.52
  • 52 Week High
  • RPTX $4.29
  • SNAL $3.42
  • Technical
  • Relative Strength Index (RSI)
  • RPTX 34.51
  • SNAL 39.74
  • Support Level
  • RPTX $0.89
  • SNAL $0.64
  • Resistance Level
  • RPTX $1.02
  • SNAL $1.70
  • Average True Range (ATR)
  • RPTX 0.07
  • SNAL 0.14
  • MACD
  • RPTX -0.01
  • SNAL 0.02
  • Stochastic Oscillator
  • RPTX 19.10
  • SNAL 31.64

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.

About SNAL Snail Inc.

Snail Inc is a global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.

Share on Social Networks: